Profound Medical (PROF) Short term Debt (2018 - 2026)

Profound Medical's Short term Debt history runs 7 years deep, the most recent figure standing at $4.5 million for Q1 2026.

• On a quarterly basis, Short term Debt changed N/A year-over-year to $4.5 million in Q1 2026; TTM through Mar 2026 was $4.5 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.7 million, down 17.44% from the prior year.
• Short term Debt improved to $4.5 million in Q1 2026 per PROF's latest filing, from $4.5 million in the prior quarter.
• Across five years, Short term Debt topped out at $4.5 million in Q1 2026 and bottomed at $523000.0 in Q4 2022.
• The 5-year median for Short term Debt is $2.1 million (2023), against an average of $2.7 million.
• Across the five-year window, Short term Debt surged 302.29% in 2023 and dropped 17.44% in 2024, its largest moves.
• Year by year, Short term Debt stood at $523000.0 in 2022, then jumped by 302.29% to $2.1 million in 2023, then declined by 17.44% to $1.7 million in 2024, then soared by 157.92% to $4.5 million in 2025, then increased by 0.51% to $4.5 million in 2026.
• Per Business Quant, the three latest PROF Short term Debt figures stand at $4.5 million (Q1 2026), $4.5 million (Q3 2025), and $1.7 million (Q4 2024).